NasdaqGM - Delayed Quote USD
Sera Prognostics, Inc. (SERA)
2.3500
+0.0300
+(1.29%)
At close: May 13 at 4:00:01 PM EDT
2.3504
+0.00
+(0.02%)
After hours: May 13 at 6:57:29 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Evguenia Lindgardt M.B.A. | President, CEO & Director | 693.4k | -- | 1975 |
| Dr. John J. Boniface Ph.D. | Chief Scientific Officer | 431.28k | -- | 1963 |
| Dr. Gregory C. Critchfield M.D., M.S. | Executive Director | 19.9k | -- | 1953 |
| Dr. Paul Kearney Ph.D. | Chief Data Officer | 468.73k | -- | 1969 |
| Mr. Austin Aerts | Chief Financial Officer | 367.62k | -- | 1988 |
| Mr. Robert G. Harrison | Chief Information Officer | 384.18k | -- | 1966 |
| Mr. Benjamin G. Jackson J.D. | General Counsel | 410.75k | -- | 1980 |
| Mr. Lee Anderson | Chief Commercial Officer | -- | -- | -- |
Sera Prognostics, Inc.
2749 East Parleys Way
Suite 200
Salt Lake City, UT 84109
United States
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 63
Description
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Corporate Governance
Sera Prognostics, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 9. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 10; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 8:05 PM UTC
Sera Prognostics, Inc. Earnings Date
Recent Events
Related Tickers
QTRX Quanterix Corporation
4.6400
-19.02%
DHAI DIH Holding US, Inc.
0.1899
+10.34%
KIDS OrthoPediatrics Corp.
23.21
-0.26%
SIBN SI-BONE, Inc.
18.59
-1.01%
ADGM Adagio Medical Holdings, Inc.
1.2800
-5.88%
INGN Inogen, Inc.
6.14
-2.54%
SSII SS Innovations International, Inc.
10.15
0.00%
IVF INVO Fertility, Inc.
1.9800
-7.04%
VREX Varex Imaging Corporation
7.50
-0.27%
RPID Rapid Micro Biosystems, Inc.
3.1600
+8.22%